460 related articles for article (PubMed ID: 30488109)
1. Myelin loss in white matter hyperintensities and normal-appearing white matter of cognitively impaired patients: a quantitative synthetic magnetic resonance imaging study.
Park M; Moon Y; Han SH; Kim HK; Moon WJ
Eur Radiol; 2019 Sep; 29(9):4914-4921. PubMed ID: 30488109
[TBL] [Abstract][Full Text] [Related]
2. Characterizing the white matter hyperintensity penumbra with cerebral blood flow measures.
Promjunyakul N; Lahna D; Kaye JA; Dodge HH; Erten-Lyons D; Rooney WD; Silbert LC
Neuroimage Clin; 2015; 8():224-9. PubMed ID: 26106546
[TBL] [Abstract][Full Text] [Related]
3. White matter hyperintensities are associated with falls in older people with dementia.
Taylor ME; Lord SR; Delbaere K; Wen W; Jiang J; Brodaty H; Kurrle SE; Stefanie Mikolaizak A; Close JCT
Brain Imaging Behav; 2019 Oct; 13(5):1265-1272. PubMed ID: 30145714
[TBL] [Abstract][Full Text] [Related]
4. Structural and functional MRI correlates of T2 hyperintensities of brain white matter in young neurologically asymptomatic adults.
Keřkovský M; Stulík J; Dostál M; Kuhn M; Lošák J; Praksová P; Hulová M; Bednařík J; Šprláková-Puková A; Mechl M
Eur Radiol; 2019 Dec; 29(12):7027-7036. PubMed ID: 31144071
[TBL] [Abstract][Full Text] [Related]
5. Brain myelin water fraction is associated with APOE4 allele status in patients with cognitive impairment.
Park M; Lee HP; Kim J; Kim DH; Moon Y; Moon WJ
J Neuroimaging; 2022 May; 32(3):521-529. PubMed ID: 34964524
[TBL] [Abstract][Full Text] [Related]
6. Exploring the Contribution of Myelin Content in Normal Appearing White Matter to Cognitive Outcomes in Cerebral Small Vessel Disease.
Dao E; Tam R; Hsiung GR; Ten Brinke L; Crockett R; Barha CK; Yoo Y; Al Keridy W; Doherty SH; Laule C; MacKay AL; Liu-Ambrose T
J Alzheimers Dis; 2021; 80(1):91-101. PubMed ID: 33523006
[TBL] [Abstract][Full Text] [Related]
7. An Exploratory Study of Pathways from White Matter Hyperintensities to Cognitive Impairment through Depressive Symptoms Using Structural Equation Modeling: A Cross Sectional Study in Patients with Dementia.
Lee CH; Kim DH
J Int Neuropsychol Soc; 2020 Aug; 26(7):679-689. PubMed ID: 32183915
[TBL] [Abstract][Full Text] [Related]
8. Investigating the microstructural properties of normal-appearing white matter (NAWM) preceding conversion to white matter hyperintensities (WMHs) in stroke survivors.
Khan W; Khlif MS; Mito R; Dhollander T; Brodtmann A
Neuroimage; 2021 May; 232():117839. PubMed ID: 33577935
[TBL] [Abstract][Full Text] [Related]
9. Associations between white matter hyperintensities, striatal dopamine loss, and cognition in drug-naïve Parkinson's disease.
Jeong SH; Lee HS; Jung JH; Baik K; Sohn YH; Chung SJ; Lee PH
Parkinsonism Relat Disord; 2022 Apr; 97():1-7. PubMed ID: 35276583
[TBL] [Abstract][Full Text] [Related]
10. White Matter Lesions in Mild Cognitive Impairment and Idiopathic Parkinson's Disease: Multimodal Advanced MRI and Cognitive Associations.
Rane S; Owen J; Hippe DS; Cholerton B; Zabetian CP; Montine T; Grabowski TJ
J Neuroimaging; 2020 Nov; 30(6):843-850. PubMed ID: 32937003
[TBL] [Abstract][Full Text] [Related]
11. Myelin Damage in Normal Appearing White Matter Contributes to Impaired Cognitive Processing Speed in Multiple Sclerosis.
Abel S; Vavasour I; Lee LE; Johnson P; Ackermans N; Chan J; Dvorak A; Schabas A; Wiggermann V; Tam R; Kuan AJ; Morrow SA; Wilken J; Laule C; Rauscher A; Bhan V; Sayao AL; Devonshire V; Li DK; Carruthers R; Traboulsee A; Kolind SH
J Neuroimaging; 2020 Mar; 30(2):205-211. PubMed ID: 31762132
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal relaxographic imaging of white matter hyperintensities in the elderly.
Anderson VC; Obayashi JT; Kaye JA; Quinn JF; Berryhill P; Riccelli LP; Peterson D; Rooney WD
Fluids Barriers CNS; 2014; 11():24. PubMed ID: 25379172
[TBL] [Abstract][Full Text] [Related]
13. Multimodal imaging findings in normal-appearing white matter of leucoaraiosis: a review.
Zhong G; Lou M
Stroke Vasc Neurol; 2016 Jun; 1(2):59-63. PubMed ID: 28959465
[TBL] [Abstract][Full Text] [Related]
14. Three-tissue compositional analysis reveals in-vivo microstructural heterogeneity of white matter hyperintensities following stroke.
Khan W; Egorova N; Khlif MS; Mito R; Dhollander T; Brodtmann A
Neuroimage; 2020 Sep; 218():116869. PubMed ID: 32334092
[TBL] [Abstract][Full Text] [Related]
15. White Matter Hyperintensities Predict Cognitive Decline: A Community-Based Study.
Qi X; Tang H; Luo Q; Ding B; Chen J; Cui P; Chen S; Ling H; Ma J
Can J Neurol Sci; 2019 Jul; 46(4):383-388. PubMed ID: 31133080
[TBL] [Abstract][Full Text] [Related]
16. Severity of White Matter Hyperintensities and Length of Hospital Stay in Patients with Cognitive Impairment: A CREDOS (Clinical Research Center for Dementia of South Korea) Study.
Chang KJ; Lee S; Lee Y; Lee KS; Back JH; Jung YK; Lim KY; Noh JS; Kim HC; Roh HW; Choi SH; Kim SY; Joon Son S; Hong CH
J Alzheimers Dis; 2015; 46(3):719-26. PubMed ID: 25854927
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal White Matter Damage Evolution in Parkinson's Disease.
Scamarcia PG; Agosta F; Spinelli EG; Basaia S; Stojković T; Stankovic I; Sarasso E; Canu E; Markovic V; Petrović I; Stefanova E; Pagani E; Kostic VS; Filippi M
Mov Disord; 2022 Feb; 37(2):315-324. PubMed ID: 34806799
[TBL] [Abstract][Full Text] [Related]
18. The impact of silent vascular brain burden in cognitive impairment in Parkinson's disease.
González-Redondo R; Toledo J; Clavero P; Lamet I; García-García D; García-Eulate R; Martínez-Lage P; Rodríguez-Oroz MC
Eur J Neurol; 2012 Aug; 19(8):1100-7. PubMed ID: 22360775
[TBL] [Abstract][Full Text] [Related]
19. White matter hyperintensity distribution differences in aging and neurodegenerative disease cohorts.
Dadar M; Mahmoud S; Zhernovaia M; Camicioli R; Maranzano J; Duchesne S;
Neuroimage Clin; 2022; 36():103204. PubMed ID: 36155321
[TBL] [Abstract][Full Text] [Related]
20. Microstructural white matter changes preceding white matter hyperintensities in migraine.
Arkink EB; Palm-Meinders IH; Koppen H; Milles J; van Lew B; Launer LJ; Hofman PAM; Terwindt GM; van Buchem MA; Ferrari MD; Kruit MC
Neurology; 2019 Aug; 93(7):e688-e694. PubMed ID: 31296653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
